Clinical Trials Browser

Phase 1 × OTHER × lorukafusp alfa × Clear all

NCT03209869 2022-09-13

Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2

Phase 1 Withdrawn

Neuroblastoma, Osteosarcoma